SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale of 1,975,000 … [Read more...] about SenesTech Announces $3.95 Million Direct Offering of Stock Priced At-the-Market Under Nasdaq Rules
senesTech
SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced private placement of 4,388,854 shares of common stock (or common stock equivalents in lieu … [Read more...] about SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market
SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, October … [Read more...] about SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules
SenesTech, Inc. (Nasdaq: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the pricing of its public offering of 1,574,308 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one … [Read more...] about SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules
New York State Approval is Major Step For SenesTech
SenesTech, a leader in technology for managing animal pest populations through fertility control, is celebrating the registration approval from New York state for the marketing and sale of ContraPest. As a result of the anticipated demand for the product to control rat infestations, the Flagstaff … [Read more...] about New York State Approval is Major Step For SenesTech
SenesTech Hires Dr. Sandra Alcaraz to Promote Regulatory Approval
SenesTech, Inc., a developer of novel proprietary technologies for managing animal pest populations through fertility control, is hiring Dr. Sandra Alcaraz as vice president, regulatory affairs. The company also is providing further details on its international expansion strategy. Dr. Alcaraz is … [Read more...] about SenesTech Hires Dr. Sandra Alcaraz to Promote Regulatory Approval
SenesTech Taps Bioceres to Seek Argentine Approval for ContraPest
A developer of proprietary technologies for managing animal pest populations through fertility control, today announced that jointly with Bioceres, a leading Argentine agricultural biotechnology company1 , it will seek Argentine regulatory approval for ContraPest®, SenesTech's patent protected … [Read more...] about SenesTech Taps Bioceres to Seek Argentine Approval for ContraPest